DLG3 (SAP-102 or NEDLG) Antibody - FFPE Validated

Scientific Overview

This antibody supports experimental designs that analyze DLG3 with interpretable controls and clear contrasts. DLG3 is a pathway component whose activation state and localization can change after stimulation. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol NEDLG.

Research Relevance

Perturbations such as inhibitors or ligand stimulation can drive rapid shifts in localization or complex formation. Time course design can be decisive when regulation is transient or compartment dependent.

When cell-state transitions occur, this target may change alongside partners in the same compartment or pathway neighborhood.

When building a narrative around the target, it helps to track:

• condition-to-condition comparisons with matched controls
• time-resolved changes following stimulation or inhibition
• localization shifts between cytoplasm, membrane, and nucleus

Application-Specific Context

In sectioned tissue workflows, interpretation often depends on morphology; this format supports that style of readout. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. Align controls to the expected direction of change to support confident interpretation.

When interpreting DLG3, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

The fixed-section format fits designs where DLG3 is evaluated with deliberate controls and careful comparisons.